Sandu Pharmaceuticals Q3FY22 net profit at Rs. 44.88 lakhs

SANDU PHARMACEUTICALS LTD. has reported Standalone financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 19.1538 crores during the period ended December 31, 2021 as compared to Rs. 17.6182 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 0.4488 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.4530 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 0.48 for the period ended December 31, 2021 as compared to Rs. 0.49 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹19.1538 crs	₹17.6182 crs	8.72%
Net Profit	₹0.4488 crs	₹0.4530 crs	-0.93%
EPS	₹0.48	₹0.49	-2.04%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs.19.1538 crores during the period ended December 31, 2021 as compared to Rs.15.8407 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.0.4488 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.2933 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.0.48 for the period ended December 31, 2021 as compared to Rs.0.41 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹19.1538 crs	₹15.8407 crs	20.92%
Net Profit	₹0.4488 crs	₹0.2933 crs	53.02%
EPS	₹0.48	₹0.41	17.07%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.54.1315 crores during the 9 Months period ended December 31, 2021 as compared to Rs.44.8226 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.1.3198 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.0.7280 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.1.47 for the 9 Months period ended December 31, 2021 as compared to Rs.1.03 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹54.1315 crs	₹44.8226 crs	20.77%
Net Profit	₹1.3198 crs	₹0.7280 crs	81.29%
EPS	₹1.47	₹1.03	42.72%

Shares of SANDU PHARMACEUTICALS LTD. was last trading in BSE at Rs. 57.65 as compared to the previous close of Rs. 57.30. The total number of shares traded during the day was 8937 in over 66 trades.

The stock hit an intraday high of Rs. 61.60 and intraday low of 55.70. The net turnover during the day was Rs. 516556.00.

Source : Equity Bulls

Keywords

SanduPharmaceuticals Q3FY22 9MFY22 ResultUpdate